Meiji Holdings Co., Ltd. Meiji Holdings Co., Ltd. Financial Results- For the First Half of FYE March 2017 -  


Phama: Establish Market Presence for Newly Launched Products and Boost Sales of Existing Products in Domestic Business

Prev. Page Next Page Download the PDF
Pharmaceuticals segment
Severe conditions have already been discounted in our forecast. The plans and strategies were reflected such external environment. We will successfully implement these strategies and achieve the revised forecast though we struggled somewhat in H1.

Domestic business
Establish market presence for newly launched products.

 - Cycrest Opened account in the major mental hospitals and university hospitals according to the plan. Promote its efficacy and safety and expand sales.

 - Ultibro Enhance promotional activities to increase sales.

 - Bilanoa New anti-histamine drug to be released in November. Quickly start promotional activities following its launch.

Expand existing drugs and generics.
Promote our strengths - high quality, information provision, and stable supply - to increase sales and share.

 - Reflex An antidepressant

 - Tazopipe An injectable antibiotic, the area of our expertise.